GlassScriptPhysician profile
Wendy Ray
NPI 1306455860
$1,756.13
in general payments reported to CMS, 2019-2025
16 companies · $604 in 2025
The $604 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $218 · 2022: $234 · 2023: $365 · 2024: $336 · 2025: $604.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,305.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,304.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $981.82 | 2021-2025 | |
| Otsuka America Pharmaceutical, INC. | $223.89 | 2022-2025 | Rexulti |
| Neurocrine Biosciences, INC. | $117.76 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $88.66 | 2022-2025 | Cobenfy |
| Vanda Pharmaceuticals INC. | $62.01 | 2025 | Fanapt, Hetlioz |
| Astellas Pharma US INC | $47.69 | 2023-2024 | Veozah |
| Novartis Pharmaceuticals Corporation | $42.62 | 2022-2023 | |
| Merck Sharp & Dohme LLC | $37.66 | 2021-2023 | Verquvo, Belsomra |
| Axsome Therapeutics, INC. | $33.98 | 2025 | Auvelity |
| Janssen Pharmaceuticals, INC | $23.51 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $19.13 | 2025 | Farxiga |
| Dexcom, INC. | $17.98 | 2024 | Dexcom G6 Transmitter |
| Exact Sciences Corporation | $15.52 | 2025 | The Cologuard Plus Collection Kit |
| Glaxosmithkline, LLC. | $15.27 | 2024 | Trelegy Ellipta |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.42 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $14.21 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wendy Ray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.